Site icon All About Cardiovascular System and Disorders

Echocardiographic Findings in Pulmonary Arterial Hypertension (PAH)

YouTube video player

Echocardiography is the first-line non-invasive imaging modality for evaluating suspected pulmonary arterial hypertension (PAH). While right heart catheterization (RHC) remains the gold standard for definitive diagnosis, an echocardiogram provides critical data on the structural impact, hemodynamic severity, and right ventricular (RV) function. Key echocardiographic findings in PAH are broken down into structural changes, hemodynamic markers, and indices of RV systolic function.

Structural Findings (2D & M-Mode)

Chronic pressure and volume overload in PAH cause progressive right-sided remodeling, often at the expense of the left heart chambers.

Hemodynamic Markers (Doppler)

Doppler interrogation is essential for estimating pulmonary pressures and assessing the probability of PAH.

Right Ventricular Function

Because RV failure drives mortality in PAH, assessing longitudinal and global RV contractility is crucial for prognosis.

MetricThreshold for DysfunctionClinical Significance
TAPSE< 17 mmTricuspid Annular Plane Systolic Excursion measures longitudinal contraction. It is highly reproducible and strongly correlates with survival.
Tissue Doppler S’< 9.5 cm/sThe peak systolic velocity of the lateral tricuspid annulus.
RV FAC< 35%Fractional Area Change offers a 2D assessment of global RV systolic function.
TAPSE/sPAP Ratio< 0.55 mm/mmHgA marker of RV-PA coupling. It assesses whether the RV contractility (TAPSE) is adequately matched to the afterload (systolic pulmonary artery pressure).

Clinical Note: The presence of a pericardial effusion is a significant, poor prognostic marker in PAH, indicating advanced right heart failure and elevated systemic venous pressures.

Exit mobile version